Three new napyradiomycins (
1–
3) were isolated from the culture broth of a marine-derived actinomycete strain SCSIO 10428, together with six known related analogues napyradiomycin A1 (
4), 18-oxonapyradiomycin A1 (
5), napyradiomycin B1 (
6), napyradiomycin
[...] Read more.
Three new napyradiomycins (
1–
3) were isolated from the culture broth of a marine-derived actinomycete strain SCSIO 10428, together with six known related analogues napyradiomycin A1 (
4), 18-oxonapyradiomycin A1 (
5), napyradiomycin B1 (
6), napyradiomycin B3 (
7), naphthomevalin (
8), and napyradiomycin SR (
9). The strain SCSIO 10428 was identified as a
Streptomyces species by the sequence analysis of its 16S rRNA gene. The structures of new compounds
1–
3, designated 4-dehydro-4a-dechlorona pyradiomycin A1 (
1), 3-dechloro-3-bromonapyradiomycin A1 (
2), and 3-chloro-6, 8-dihydroxy-8-α-lapachone (
3), respectively, were elucidated by comparing their 1D and 2D NMR spectroscopic data with known congeners. None of the napyradiomycins
1–
9 showed antioxidative activities. Napyradiomycins
1–
8 displayed antibacterial activities against three Gram-positive bacteria
Staphylococcus and
Bacillus strains with MIC values ranging from 0.25 to 32 μg mL
−1, with the exception that compound
3 had a MIC value of above 128 μg mL
−1 against
Staphylococcus aureus ATCC 29213. Napyradiomycins
2,
4,
6, and
7 exhibited moderate cytotoxicities against four human cancer cell lines SF-268, MCF-7, NCI-H460, and HepG-2 with IC
50 values below 20 μM, while the IC
50 values for other five napyradiomycins
1,
3,
5,
8 and
9 were above 20 μM.
Full article